☆ 4.6 Meeting Abstract

COST ANALYSIS, SAFETY, AND EFFICACY OF PEMETREXED/CISPLATIN COMPARED WITH BEVACIZUMAB/GEMCITABINE/CISPLATIN IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED NON-SQUAMOUS NSCLC IN RUSSIA

VALUE IN HEALTH (2011)

Get Full Text
Add to Collection

Journal

VALUE IN HEALTH
Volume 14, Issue 3, Pages A161-A161

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jval.2011.02.894

Keywords

-

Categories

Economics Health Care Sciences & Services Health Policy & Services

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.